Cornerstone reference

The A-Z Peptide Bible

A free, single-page reference to the research peptides most commonly studied in the published peer-reviewed literature. Each entry summarises sequence, class, mechanism, half-life, stability and a primary citation, plus a link to the full reference page if we stock the compound. Last updated 29 April 2026 by Joe, founder.

Research use only. The compounds described on this page are supplied for in-vitro laboratory research. None of the content here is medical advice, dosing guidance or a recommendation for human use.

ABCDEFGHIJKLMNOPQRSTUVWXYZ
How to use this page. Tap a letter above to jump to it. Each entry has a green Stocked tag (compound supplied by Lab77 Peptides) or a grey Reference tag (well-cited in the literature, not stocked by us). Stocked compounds link to the full product reference page where you can see pricing, full literature summary and Janoshik HPLC samples. The data shown (half-life, sequence, MW) is drawn from primary published research and is intended as a starting point for your own laboratory characterisation, not a complete spec sheet.

A

9 entries

Adipotide

FTPP; CKGGRAKDC-GG-D(KLAKLAK)2

A peptidomimetic chimera that targets prohibitin on the surface of white adipose vasculature, characterised in published preclinical literature for adipose-specific apoptotic research models. Distinctive for its tissue-targeting domain rather than a receptor-agonist mechanism.

ClassPro-apoptotic peptidomimetic chimera
Molecular weight2611.21 g/mol
Half-lifeShort (hours, literature)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetProhibitin (white-adipose vasculature)

Ara-290

Cibinetide; ARA-290; Helix B Surface Peptide

An 11-amino-acid synthetic peptide derived from the helix B surface of erythropoietin (EPO) and engineered to bind the heteromeric tissue-protective receptor (EPOR/CD131) without the haematopoietic activity of EPO itself. Characterised in inflammation and tissue-repair literature.

ClassEPO-derived 11-AA tissue-protective peptide
SequenceQEQLERALNSS
Molecular weight1257.27 g/mol
Half-life~2 minutes (literature, plasma)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetEPO receptor / CD131 heteromer

Angiotensin II

AT-II

An octapeptide hormone of the renin-angiotensin system (RAS), one of the most extensively cited reference peptides in cardiovascular and renal pharmacology. Listed here as a reference; stocked separately as a research-grade reference standard from specialist suppliers.

ClassRAS octapeptide hormone
SequenceDRVYIHPF
Molecular weight1046.18 g/mol
Half-life~30 seconds (serum, literature)
TargetAT1 / AT2 receptors
Reference only Not currently stocked. See Metabolic Research for related compounds.

B

2 entries

BPC-157

Body Protection Compound-157; Pentadecapeptide BPC-157

A 15-amino-acid synthetic peptide derived from a partial sequence of human gastric juice protein. One of the most widely cited regenerative-research peptides, characterised in extensive preclinical literature for tendon, gut-mucosal and connective-tissue repair models.

ClassPentadecapeptide (gastric juice fragment)
SequenceGEPPPGKPADDAGLV
CAS137525-51-0
Molecular weight1419.53 g/mol
Half-life~4 hours (reconstituted, literature)
StabilityLyophilised stable 24+ months at 2–8 °C; reconstituted ~14 days at 2–8 °C

B12 (Methylcobalamin)

Vitamin B12; Mecobalamin

The methylated, biologically active form of vitamin B12 used as a research reference standard in metabolic, neurological and haematology pharmacology. Not a peptide chemically (it is a corrin-cobalt complex) but supplied as a research-grade reagent alongside the peptide catalogue.

ClassCobalamin (corrin-cobalt complex)
CAS13422-55-4
Molecular weight1344.40 g/mol
StabilityLight-sensitive; lyophilised stable 24+ months at 2–8 °C in amber vial

C

3 entries

Cagrilintide

AM833

A long-acting amylin analogue characterised in published metabolic-research literature, frequently studied in combination with semaglutide as a dual-mechanism research compound. Acts at amylin and calcitonin receptor family targets.

ClassLong-acting amylin analogue
CAS1415456-99-3
Molecular weight3879.4 g/mol
Half-life~6–8 days (literature)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetAmylin (AMY1, AMY3) receptor family

CJC-1295 (without DAC)

Modified GRF 1-29; ModGRF

The same modified GHRH backbone as CJC-1295 (DAC) but lacking the albumin-binding maleimide. Half-life is approximately 30 minutes, longer than native GHRH(1-29) but much shorter than the DAC-modified version. Widely cited in pulsatile GH-research.

ClassModified GHRH 1-29 analogue
Molecular weight3367.9 g/mol
Half-life~30 minutes (serum, literature)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetGHRH receptor (GHRHR)

D

2 entries

DSIP

Delta Sleep-Inducing Peptide

A 9-amino-acid neuropeptide originally isolated from rabbit cerebral venous blood and characterised in CNS / sleep-architecture research literature. The mechanism in published research is not fully resolved; multiple receptor-system interactions are reported.

Class9-AA neuropeptide
SequenceWAGGDASGE
CAS62568-57-4
Molecular weight848.8 g/mol
Half-life~7–15 minutes (serum, literature)
StabilityLyophilised stable 24+ months at 2–8 °C

E

2 entries

Epithalon

Epitalon; AEDG tetrapeptide

A short 4-amino-acid synthetic peptide originating from research at the St Petersburg Institute of Bioregulation and Gerontology. Characterised in published Russian literature for telomerase / pineal-gland research models.

Class4-AA bioregulator tetrapeptide
SequenceAEDG (Ala-Glu-Asp-Gly)
CAS307297-39-8
Molecular weight390.35 g/mol
StabilityLyophilised stable 24+ months at 2–8 °C

Exenatide

Exendin-4

A 39-amino-acid peptide originally isolated from the salivary secretions of the Gila monster (Heloderma suspectum) and acting as a GLP-1 receptor agonist with greater enzymatic stability than native GLP-1. One of the most extensively cited GLP-1 reference compounds in incretin literature.

ClassGLP-1 receptor agonist (39-AA peptide)
CAS141758-74-9
Molecular weight4186.6 g/mol
Half-life~2.4 hours (literature)
TargetGLP-1 receptor
Reference only Not currently stocked. See Metabolic Research for related GLP-1 compounds.

F

2 entries

FOXO4-DRI

FOXO4 D-Retro-Inverso peptide

A D-amino-acid retro-inverso peptide engineered to disrupt the FOXO4-p53 interaction, characterised in published senescence-research literature for selective senolytic activity in preclinical models.

ClassD-retro-inverso senolytic peptide
SequenceD-LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRPPPRRRQRRKKRG (D-amino acids)
Molecular weight5234.2 g/mol
TargetFOXO4 / p53 protein-protein interaction
Reference only Not currently stocked. Citation: Baar et al. 2017

Follistatin

FST-315; FST-344

An autocrine glycoprotein characterised in published myostatin / activin signalling literature as an antagonist of activin and myostatin via direct binding. Both 315-residue and 344-residue isoforms are studied.

ClassActivin / myostatin antagonist glycoprotein
Molecular weight~32–38 kDa
TargetActivin A, Myostatin (GDF-8)
Reference only Not currently stocked. See Regenerative Research for related compounds.

G

5 entries

GHK-Cu

Copper Tripeptide-1; Glycyl-L-histidyl-L-lysine:copper

A tripeptide-copper complex consisting of glycyl-L-histidyl-L-lysine bound to a Cu²⁺ ion. One of the most extensively cited regenerative-research peptides, with hundreds of publications spanning copper biochemistry, collagen synthesis, and dermal-research models.

ClassCopper-binding tripeptide complex
SequenceGHK + Cu²⁺
CAS89030-95-5
Molecular weight340.83 g/mol (complex)
StabilityLight-sensitive; lyophilised stable 24+ months at 2–8 °C in amber vial

Glutathione

GSH; reduced glutathione; gamma-Glu-Cys-Gly

A 3-amino-acid intracellular tripeptide (gamma-Glu-Cys-Gly) and the principal endogenous low-molecular-weight thiol antioxidant in mammalian cells. Widely used as a reference standard in redox-biology research.

ClassEndogenous tripeptide thiol antioxidant
Sequenceγ-Glu-Cys-Gly
CAS70-18-8
Molecular weight307.32 g/mol
StabilityAir-sensitive (oxidises to GSSG); lyophilised stable at 2–8 °C

Gonadorelin

GnRH; LHRH; Gonadotropin-Releasing Hormone

A 10-amino-acid hypothalamic decapeptide and the natural ligand for the GnRH receptor on pituitary gonadotrophs. The canonical reference standard for HPG-axis pharmacology research.

ClassHypothalamic decapeptide
SequencepyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂
CAS33515-09-2
Molecular weight1182.31 g/mol
Half-life~2–4 minutes (serum, literature)
TargetGnRH receptor
Reference only Not currently stocked. See Neuropeptide Research for related compounds.

H

3 entries

HCG

Human Chorionic Gonadotropin

A heterodimeric glycoprotein hormone with an alpha subunit shared with LH/FSH/TSH and a beta subunit specific to HCG. The canonical reference standard for LH receptor pharmacology research.

ClassHeterodimeric glycoprotein hormone
CAS9002-61-3
Molecular weight~36.7 kDa
Half-life~24–36 hours (serum, literature)
TargetLH receptor (LHCGR)
Stocked View HCG ›

HGH (Somatropin)

Human Growth Hormone; Somatotropin; Recombinant hGH 1-191

A 191-amino-acid recombinant human growth hormone identical in sequence to the endogenous pituitary peptide. The canonical reference standard for GH receptor / JAK2-STAT5 signalling research.

ClassRecombinant 191-AA peptide hormone
CAS12629-01-5
Molecular weight22.1 kDa
Half-life~3.5 hours (serum, literature)
TargetGH receptor (GHR)
Stocked View HGH ›

Hexarelin

Examorelin

A 6-amino-acid synthetic GH secretagogue closely related to GHRP-6, characterised in published GH-axis literature. Reported in research as having additional CD36-mediated cardiovascular activity beyond GHS-R1a binding.

ClassSynthetic GHS hexapeptide
SequenceHis-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂
CAS140703-51-1
Molecular weight887.04 g/mol
TargetGHS-R1a; CD36
Reference only Not currently stocked. See GH-axis Research for related GHS compounds.

I

2 entries

IGF-1 LR3

Long R3 IGF-1; Long Arg3 Insulin-like Growth Factor-1

A 83-amino-acid analogue of IGF-1 with an additional 13-residue N-terminal extension and an arginine substitution at position 3. Reduced binding to IGF binding proteins gives an extended half-life relative to native IGF-1.

ClassModified IGF-1 analogue
CAS946870-92-4
Molecular weight9111.4 g/mol
Half-life~20–30 hours (literature, reduced IGFBP binding)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetIGF-1 receptor (IGF1R)

Ipamorelin

NNC 26-0161

A 5-amino-acid selective ghrelin-mimetic GH secretagogue. Distinct from GHRP-2 and GHRP-6 in that the published profile reports minimal cortisol or prolactin release, making it the most selective GHS-R1a compound for research purposes.

ClassSelective GHS pentapeptide
SequenceAib-His-D-2-Nal-D-Phe-Lys-NH₂
CAS170851-70-4
Molecular weight711.86 g/mol
Half-life~2 hours (serum, literature)
TargetGHS-R1a (selective)

J

No common entries

No widely-cited research peptides start with J. The closest reference standards are Jasplakinolide (an actin-stabilising marine cyclic peptide used in cell biology) and Jingzhaotoxin (a spider toxin used in ion-channel research) - neither is supplied as a research-peptide reference.

K

2 entries

Kisspeptin-10

Metastin 45-54; Kp-10

The C-terminal 10-amino-acid fragment of the 54-residue Kisspeptin-54 / Metastin precursor and a high-affinity ligand at the GPR54 (KISS1R) receptor. The canonical reference compound for hypothalamic-pituitary-gonadal (HPG) axis research.

ClassHypothalamic decapeptide
SequenceYNWNSFGLRF-NH₂
CAS374675-21-5
Molecular weight1302.46 g/mol
Half-life~4 minutes (serum, literature)
TargetKISS1R / GPR54

KLOW Blend

Kisspeptin / Lipid / Oxytocin / WAT-targeting research blend

A research-use blend formulation studied for parallel multi-pathway research models. Composition is supplied with the order; refer to the product page for the precise blend ratio of the current batch.

ClassMulti-peptide research blend
StabilityLyophilised stable 24+ months at 2–8 °C

L

2 entries

LL-37

Cathelicidin antimicrobial peptide; CAMP

A 37-amino-acid host-defence peptide processed from the human cathelicidin precursor hCAP-18. Characterised across innate-immunity literature for broad antimicrobial and immunomodulatory activity.

ClassHost-defence cathelicidin peptide
SequenceLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
CAS154947-66-7
Molecular weight4493.33 g/mol
TargetMicrobial membranes; FPRL1; P2X7
Reference only Not currently stocked.

M

6 entries

MOTS-C

Mitochondrial-derived peptide

A 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. Characterised in metabolic-research literature for AMPK-mediated effects in skeletal muscle and adipose models.

ClassMitochondrial-derived peptide (MDP)
SequenceMRWQEMGYIFYPRKLR
Molecular weight2174.6 g/mol
StabilityLyophilised stable 24+ months at 2–8 °C
MechanismAMPK activation; folate-cycle modulation
Stocked View MOTS-C › Citation: Lee et al. 2015

MT-1 (Afamelanotide)

Melanotan-1; NDP-MSH; [Nle&sup4;, D-Phe⁷]-α-MSH

A 13-amino-acid synthetic analogue of alpha-melanocyte-stimulating hormone with a norleucine-4 and D-phenylalanine-7 substitution that increases potency and metabolic stability at melanocortin receptors.

Classα-MSH analogue (13-AA)
SequenceAc-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂
CAS75921-69-6
Molecular weight1646.85 g/mol
TargetMelanocortin receptors (MC1R selectivity)

MT-2 (Melanotan 2)

Melanotan-II; Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂

A 7-amino-acid cyclic synthetic analogue of alpha-MSH with a lactam bridge between Asp² and Lys⁷. The cyclic structure provides metabolic stability and broad melanocortin receptor agonism.

ClassCyclic 7-AA α-MSH analogue
CAS121062-08-6
Molecular weight1024.18 g/mol
TargetMC1R / MC3R / MC4R / MC5R (broad)
Stocked View MT-2 ›

MGF / PEG-MGF

Mechano Growth Factor; IGF-1Ec splice variant

A splice variant of the IGF-1 gene producing a 24-amino-acid C-terminal peptide called MGF, characterised in published muscle-research literature for its role in mechanical-load-induced satellite cell activation. PEG-MGF refers to the polyethylene-glycolated stabilised form.

ClassIGF-1 splice variant peptide (24-AA)
SequenceYQPPSTNKNTKSQRRKGSTFEERK
Molecular weight2867.1 g/mol
Half-life~minutes native; ~hours PEG-MGF (literature)
Reference only Not currently stocked. See Regenerative Research for related compounds.

N

1 entry

NAD+

Nicotinamide adenine dinucleotide

A pyridine dinucleotide cofactor essential to redox metabolism, energy production and sirtuin / PARP signalling. Not a peptide chemically (it is a dinucleotide) but supplied as a research-grade reference standard alongside the peptide catalogue. Widely cited in mitochondrial and ageing-research literature.

ClassPyridine dinucleotide cofactor
CAS53-84-9
Molecular weight663.43 g/mol
StabilityHygroscopic; lyophilised stable at -20 °C
MechanismRedox cofactor; sirtuin / PARP / CD38 substrate
Stocked View NAD+ ›

O

1 entry

P

1 entry

PT-141 (Bremelanotide)

Bremelanotide; PT141

A cyclic 7-amino-acid heptapeptide melanocortin agonist derived from MT-2 by replacing the C-terminal amide with a free carboxylic acid. Characterised in published literature for selectivity towards MC4R / MC3R relative to MC1R.

ClassCyclic 7-AA melanocortin agonist
CAS189691-06-3
Molecular weight1025.18 g/mol
Half-life~2 hours (serum, literature)
TargetMC4R / MC3R (selective)
Stocked View PT-141 ›

Q

No common entries

No widely-cited research peptides start with Q.

R

1 entry

Retatrutide

LY3437943

A 39-amino-acid synthetic peptide and triple agonist at the GLP-1, GIP and glucagon receptors. Characterised in published Phase 2 metabolic-research literature with the largest reported weight-related outcomes of any single-compound incretin programme to date.

ClassGLP-1 / GIP / glucagon triple agonist
CAS2381089-83-2
Molecular weight4731.43 g/mol
Half-life~6 days (~144 hours, literature)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetGLP-1R + GIPR + GCGR

S

4 entries

Selank

TP-7-tuftsin analogue

A 7-amino-acid synthetic peptide originating from research at the V.V. Zakusov Research Institute of Pharmacology. A heptapeptide analogue of the immunomodulatory tetrapeptide tuftsin, characterised in published literature for anxiolytic and GABAergic research.

Class7-AA tuftsin analogue
SequenceTKPRPGP
CAS129954-34-3
Molecular weight751.86 g/mol
Half-life~minutes (serum, literature)
Stocked View Selank ›

Semax

Met-Glu-His-Phe-Pro-Gly-Pro; Russian nootropic peptide

A 7-amino-acid synthetic peptide derived from the ACTH(4-10) fragment with a C-terminal Pro-Gly-Pro tripeptide added for enzymatic stability. Characterised in published Russian neuroscience literature for BDNF / NGF modulation in CNS-research models.

Class7-AA ACTH(4-10) analogue
SequenceMEHFPGP
CAS80714-61-0
Molecular weight813.93 g/mol
Half-life~minutes (intranasal, literature)
Stocked View Semax ›

Sermorelin

GHRH(1-29); GRF(1-29)

A 29-amino-acid synthetic peptide corresponding to the first 29 residues of native human growth-hormone-releasing hormone. The canonical reference standard for GHRH receptor pharmacology research.

ClassGHRH(1-29) reference peptide
CAS86168-78-7
Molecular weight3358.0 g/mol
Half-life~10–20 minutes (serum, literature)
TargetGHRH receptor (GHRHR)

T

4 entries

TB-500

Thymosin Beta-4 fragment; LKKTETQ-related

A synthetic fragment representing the active region of full-length Thymosin Beta-4 (the actin-binding 17-LKKTETQ-23 motif and surrounding residues). Characterised in published literature for actin sequestration and angiogenesis-related tissue-repair models.

ClassThymosin Beta-4 active fragment
CAS77591-33-4
StabilityLyophilised stable 24+ months at 2–8 °C
TargetG-actin sequestration
Stocked View TB-500 ›

Tesamorelin

TH9507; trans-3-hexenoyl-GHRH(1-44)NH₂

A 44-amino-acid GHRH analogue corresponding to native human GHRH(1-44) with a trans-3-hexenoyl moiety attached to the N-terminus to enhance enzymatic stability. Characterised in published literature for adipose-distribution research models.

ClassN-acylated GHRH(1-44) analogue
CAS901758-09-6
Molecular weight5135.9 g/mol
Half-life~26 minutes (serum, literature)
TargetGHRH receptor (GHRHR)

Thymosin Alpha-1

Tα1; Thymalfasin

A 28-amino-acid acetylated peptide derived from the prothymosin alpha precursor, originally isolated from bovine thymic extracts. Widely cited in immunomodulatory research as a TLR-9 / TLR-2 modulator.

Class28-AA acetylated thymic peptide
CAS62304-98-7
Molecular weight3108.32 g/mol
Half-life~2 hours (serum, literature)
TargetTLR-9 / TLR-2; T-cell modulation

Tirzepatide

LY3298176

A 39-amino-acid synthetic peptide and dual agonist at the GIP and GLP-1 receptors with a C20 fatty-diacid moiety enabling albumin binding. The most cited dual incretin reference compound in current metabolic-research literature.

ClassGIP / GLP-1 dual agonist (acylated)
CAS2023788-19-2
Molecular weight4813.45 g/mol
Half-life~5 days (serum, literature)
StabilityLyophilised stable 24+ months at 2–8 °C
TargetGIPR + GLP-1R
Stocked View Tirzepatide › Compare: Semaglutide vs Retatrutide

U

No common entries

No widely-cited research peptides start with U.

V

1 entry

VIP (Vasoactive Intestinal Peptide)

Vasoactive Intestinal Polypeptide

A 28-amino-acid peptide hormone of the secretin / glucagon superfamily, released from neurons throughout the central and peripheral nervous system. The reference standard for VPAC1 / VPAC2 receptor research.

ClassSecretin-family neuropeptide (28-AA)
CAS37221-79-7
Molecular weight3326.79 g/mol
Half-life~2 minutes (serum, literature)
TargetVPAC1 / VPAC2 receptors
Reference only Not currently stocked.

W

No common entries

No widely-cited research peptides start with W.

X

No common entries

No widely-cited research peptides start with X.

Y

No common entries

No widely-cited research peptides start with Y.

Z

No common entries

No widely-cited research peptides start with Z.

About this reference

This Bible is maintained by Joe, founder of Lab77 Peptides. The data shown is drawn from the published peer-reviewed literature: PubMed primary research, ChemSpider / PubChem chemistry data, and where applicable the published patent record. Half-lives and molecular weights are rounded to literature precision and should be confirmed against your own laboratory characterisation before use.

If you spot an error or want a compound added to the next update, message us on WhatsApp +44 7943 410496 or email info@lab77peptides.co.uk. Real human reply, usually within working hours the same day.

Next pages to read: New to research peptides? Start here · What HPLC actually means · UK legal framework for research peptides · Blog